Skip to content

Prevalence and Incidence of Multiple Revisions Following Knee Arthroplasty in Denmark 1998-2021: A Nationwide Population-based Study

Prevalence and Incidence of Multiple Revisions Following Knee Arthroplasty in Denmark 1998-2021: A Nationwide Population-based Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06064318
Acronym
EMKAR ONE
Enrollment
161384
Registered
2023-10-03
Start date
2023-02-01
Completion date
2024-04-01
Last updated
2025-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Replacement, Knee Replacement Revision

Brief summary

The purpose of this study is to investigate the incidence and prevalence rates of multiply revised knee arthroplasty patients in Denmark from 1998-2021.

Interventions

PROCEDURERevision

Any type of knee revision, excluding knee arthrodesis and femur amputation

Sponsors

Odense University Hospital
CollaboratorOTHER
Bispebjerg Hospital
CollaboratorOTHER
Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Danish Resident * all ages * must have had primary knee arthroplasty procedure performed in Denmark between 1998-2021

Exclusion criteria

* Missing key variables (patient ID, date of surgery, procedure-code, laterality of procedure) * Duplicates * Non-relevant procedures

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of major n-grade revisions23 yearsstandardized prevalence of major n-grade revisions
Incidence of major n-grade revisions23 yearsstandardized incidence of major n-grade revisions
Prevalence of all n-grade revisions23 yearsstandardized prevalence of all n-grade revisions
Incidence of all n-grade revisions23 yearsstandardized incidence of all n-grade revisions

Secondary

MeasureTime frameDescription
Prevalence of major and all n-grade revisions stratified by sex and age23 yearsCalculation of prevalence for major and for all n-grade revisions stratified by sex and by age (groups, sex: male/female, age: 18-49/50-69/70-99)
Prevalence of major and all n-grade revisions for patients with their total sum of revisions23 YearsCalculation of standardized prevalence for patients receiving major or all type of n-grade revision, where the ordering of revisions are not knee specific but patient-specific
Incidence of major and all n-grade revisions stratified by sex and age23 yearsCalculation of incidence for major and for all n-grade revisions stratified by sex and by age (groups, sex: male/female, age: 18-49/50-69/70-99)

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026